Nacuity Pharmaceuticals

Fort Worth, TX · Founded 2017 · Privately Held (backing)

Operator of a biotechnology company intended to offer treatments for retinitis pigmentosa and other ophthalmological disorders. Nacuity Pharmaceuticals is based in Fort Worth, TX and was founded in 2017. Its last reported valuation was $52 million in Jun 2022. It has raised $40.6 million across 4 recorded rounds; the latest was an $8.4 million early-stage round in Dec 2025.

Last reported valuation
$52.0M
Oct 2026
Priced at
—
Total raised
$40.6M
Last round
Early Stage VC
Dec 2025
What is Nacuity Pharmaceuticals worth?
$52.0Mlast reported valuation · Oct 2026

Nacuity Pharmaceuticals's last reported valuation, Jun 2022. Nothing priced has surfaced since.

Free account
More of Nacuity Pharmaceuticals with a free account
  • ·Watch Nacuity Pharmaceuticals: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Nacuity Pharmaceuticals funding history

4 rounds
DateRoundRaisedPost-money
Dec 2025Early Stage VC$8.4M▮
Mar 2021Early Stage VC$11.6M▮
Jun 2017Early Stage VC$9.2M▮
Nov 2016Seed Round$2.0M▮
Unlock post-money valuations

Membership and data by Private Market View

Nacuity Pharmaceuticals valuation

Nacuity Pharmaceuticals's last reported valuation was $52 million in Jun 2022. No priced round, secondary trade or fund mark has surfaced since.

How much has Nacuity Pharmaceuticals raised?

Nacuity Pharmaceuticals has raised $40.6 million across 4 recorded rounds since 2016. The largest was a $9.2 million early-stage round in Jun 2017; the most recent was an $8.4 million early-stage round in Dec 2025.

Nacuity Pharmaceuticals has filed 5 Form Ds with the SEC since 2016, most recently in Jan 2022 ($11.6 million sold to 144 investors).

How Nacuity Pharmaceuticals's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Nacuity Pharmaceuticals, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →

Frequently asked about Nacuity Pharmaceuticals

What is Nacuity Pharmaceuticals worth?
Nacuity Pharmaceuticals is valued at $52.0M as of Oct 2026. Nacuity Pharmaceuticals's last reported valuation, Jun 2022. Nothing priced has surfaced since.
How much has Nacuity Pharmaceuticals raised?
Nacuity Pharmaceuticals has raised $40.6M in total funding across 4 recorded rounds.
When did Nacuity Pharmaceuticals last raise?
Nacuity Pharmaceuticals last raised in Dec 2025 (Early Stage VC), raising $8.4M.